PubMed 25065940
Referenced in: none
Automatically associated channels: TRP , TRPA , TRPA1
Title: Structure-affinity relationships and pharmacological characterization of new alkyl-resorcinol cannabinoid receptor ligands: Identification of a dual cannabinoid receptor/TRPA1 channel agonist.
Authors: Antonella Brizzi, Francesca Aiello, Pietro Marini, Maria Grazia Cascio, Federico Corelli, Vittorio Brizzi, Luciano De Petrocellis, Alessia Ligresti, Livio Luongo, Stefania Lamponi, Sabatino Maione, Roger G Pertwee, Vincenzo Di Marzo
Journal, date & volume: Bioorg. Med. Chem., 2014 Sep 1 , 22, 4770-83
PubMed link: http://www.ncbi.nlm.nih.gov/pubmed/25065940
Abstract
In our ongoing program aimed at deeply investigating the endocannabinoid system (ES), a set of new alkyl-resorcinol derivatives was prepared focusing on the nature and the importance of the carboxamide functionality. Binding studies on CB1 and CB2 receptors, monoacylglycerol lipase (MAGL) and fatty acid amide hydrolase (FAAH) showed that some of the newly developed compounds behaved as very potent cannabinoid receptor ligands (Ki in the nanomolar range) while, however, none of them was able to inhibit MAGL and/or FAAH. Derivative 11 was a potent CB1 and CB2 ligand, with Ki values similar to WIN 55,212, exhibiting a CB1 and CB2 agonist profile in vitro. In the formalin test of peripheral acute and inflammatory pain in mice, this compound showed a weak and delayed antinociceptive effect against the second phase of the nocifensive response, exhibiting, interestingly, a quite potent transient receptor potential ankyrin type-1 (TRPA1) channel agonist activity. Moreover, derivative 14, characterized by lower affinity but higher CB2 selectivity than 11, proved to behave as a weak CB2 competitive inverse agonist.